Altamira Therapeutics Ltd. Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement
Altamira Therapeutics Ltd. (CYTOF) reported Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement of CHF 1.04 for the 12-month period ending 2018-12-31, per its 20-F filed 2019-03-14.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement · last filed 2019-03-14
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement 12 month |
|---|---|
| 2018-12-31 | 1.04 CHF 20-F · filed 2019-03-14 |
| 2017-12-31 | 0.82 CHF 20-F · filed 2018-03-22 |
| 2016-12-31 | 1.99 CHF 20-F · filed 2018-03-22 |